Mixed open over earnings


The markets opened mixed with the Dow losing 25 points to 20,498 while Nasdaq gained 33 points to 5,882 as investors monitored earnings news.

On the upside

Soligenix (Nasdaq: SNGS) will present results from its ricin toxin vaccine development program at the 20th Annual Conference on Vaccine Research on April 25.

Ultragenyx Pharmaceutical (Nasdaq: RARE) reported positive results from a Phase 3 study of burosumab to treat X-linked hypophosphatemia.

Lam Research (Nasdaq: LRCX) reported sharply higher third quarter earnings that beat analyst expectations.

On the downside

Sunshine Heart (Nasdaq: SSH) priced its public offering of common stocks and warrants at the discounted price of $1.00 per unit.

International Business Machines (NYSE: IBM) disappointed with lower fourth quarter revenue that fell short of expectations.


Investors locked in profits on Interpace Diagnostics Group (Nasdaq: IDXG).

In the broad market, advancing issues outpaced decliners by a margin of 5 to 2 on the NYSE and by more than 5 to 2 on Nasdaq. The broader S&P 500 index gained 6 points to 2,348. Bitcoin held steady at $1206.

About this Entry

This page contains a single entry by published on April 19, 2017 6:46 AM.

Markets plunge over economic data was the previous entry in this blog.

Snapchat introduces World Lenses is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12